Correction: Calcium electroporation for treatment of sarcoma in preclinical studies (Oncotarget (2018) 9 (11604-11618) DOI: 10.18632/oncotarget.24352);Calcium electroporation for treatment of sarcoma in preclinical studies

Oncotarget

Volumn 9, Issue 14, 2018, Pages 11604-11618

  Szewczyk, Anna ^a   Gehl, Julie ^b,c,d   Daczewska, Malgorzata ^a   Saczko, Jolanta ^e   Frandsen, Stine Krog ^b,d   Kulbacka, Julita ^e  

^a UNIVERSITY OF WROC AW   (Poland)

^b ZEALAND UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Calcium channels; Calcium electroporation; Cytoskeleton; PMCA; Sarcoma

Indexed keywords

ACTIN; CALCIUM; NCX1 PROTEIN; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; RYANODINE RECEPTOR 1; SODIUM CALCIUM EXCHANGE PROTEIN; UNCLASSIFIED DRUG; ZYXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C2C12 CELL LINE; CALCIUM CELL LEVEL; CALCIUM ELECTROPORATION; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; ELECTROPORATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MOUSE; MTS ASSAY; NONHUMAN; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; RHABDOMYOSARCOMA CELL; SARCOMA; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 85042223811     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.24352     Document Type: Erratum

References (55)

1. Weiss SW, Goldblum J. Rhabdomyosarcoma. In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss's soft tissue tumors. St. Louis: CV Mosby. 2001; 785-835
2. Wexler LH, Crist WM, Helman LJ. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins. 2002; 939-71
3. Casas M, Figueroa R, Jorquera G, Escobar M, Molgo J, Jaimovich E. IP3-dependent, post-tetanic calcium transients induced by electrostimulation of adult skeletal muscle fibers. J Gen Physiol. 2010; 136:455-67
4. Clapham DE. Calcium signaling. Cell. 2007; 131:1047-58
5. Strehler EE, Treiman M. Calcium pumps of plasma membrane and cell interior. Curr Mol Med. 2004; 4:323-35
6. Görlach A, Bertram K, Hudecova S, Krizanova O. Calcium and ROS: A mutual interplay. Redox Biol. 2015; 6:260-71
7. Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res. 2012; 72:1336-41
8. Zielichowska A, Daczewska M, Saczko J, Michel O, Kulbacka J. Applications of calcium electroporation to effective apoptosis induction in fibrosarcoma cells and stimulation of normal muscle cells. Bioelectrochemistry. 2016; 109:70-8
9. Zhivotovsky B, Orrenius S. Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium. 2011; 50:211-21
10. Frandsen SK, Krüger MA, Mangalanathan UM, Tramm T, Mahmood F, Novak I. Normal and Malignant Cells Exhibit Differential Responses to Calcium Electroporation. Cancer Res. 2017; 77:4389-440
11. Hansen EL, Sozer EB, Romeo S, Frandsen SK, Vernier PT, Gehl J. Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength. PLoS One 2015; 10:e0122973
12. Frandsen SK, Gibot L, Madi M, Gehl J, Rols MP. Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model. PLoS One 2015; 10:e0144028
13. Frandsen SK, Gehl J. Effect of calcium electroporation in combination with metformin in vivo and correlation between viability and intracellular ATP level after calcium electroporation in vitro. PLoS One. 2017; 12:e0181839
14. Guerini D. The significance of the isoforms of plasma membrane calcium ATPase. Cell Tissue Res. 1998; 292:191-97
15. Gao Y, Wheatly MG. Characterization and expression of plasma membrane Ca2+ ATPase (PMCA3) in the crayfish Procambarus clarkii antennal gland during molting. J Exp Biol. 2004; 207:2991-3002
16. Greeb J, Shull GE. Molecular cloning of a third isoform of the calmodulin-sensitive plasma membrane Ca2+-transporting ATPase that is expressed predominantly in brain and skeletal muscle. J Biol Chem. 1989; 264:18569-76
17. Roberts-Thomson SJ, Curry MC, Monteith GR. Plasma membrane calcium pumps and their emerging roles in cancer. World J Biol Chem. 2010; 1:248-53
18. Brini M, Carafoli E. The Plasma Membrane Ca2+ ATPase and the Plasma Membrane Sodium Calcium Exchanger Cooperate in the Regulation of Cell Calcium. Cold Spring Harb Perspect Biol. 2011; 3:a004168
19. Eymery A, Callanan M, Vourc'h C. The secret message of heterochromatin: new insights into the mechanisms and function of centromeric and pericentric repeat sequence transcription. Int J Dev Biol. 2009; 53:259-68
20. Kroemer G. Mitochondria in cancer. Oncogene. 2006; 25:4630-2
21. Guerini D, Garcia-Martin E, Zecca A, Guidi F, Carafoli E. The calcium pump of the plasma membrane: membrane targeting, calcium binding sites, tissue-specific isoform expression. Acta Physiol ScandSuppl. 1998; 643:265-73
22. Meng X, Riordan NH, Riordan HD, Mikirova N, Jackson J, González MJ, Miranda-Massari JR, Mora E, Trinidad Castillo W. Cell membrane fatty acid composition differs between normal and malignant cell lines. P R Health Sci J. 2004; 23:103-6
23. Gehlert S, Bloch W, Suhr F. Ca2+-dependent regulations and signaling in skeletal muscle: from electro-mechanical coupling to adaptation. Int J Mol Sci. 2015; 16:1066-95
24. Monteith GR, Davis FM, Roberts-Thomson SJ. Calcium Channels and Pumps in Cancer: Changes and Consequences. J Biol Chem. 2012; 287:31666-73
25. Rohwedel J, Maltsev V, Bober E, Arnold HH, Hescheler J, Wobus AM. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol. 1994; 164:87-101
26. Calì T, Ottolini D, Brini M. The Plasma Membrane Ca2+ ATPases: Isoform Specificity and Functional Versatility. In: Chakraborti S, Dhalla NS, editors. Regulation of Ca2+-ATPases,V-ATPases and F-ATPases in Advances in Biochemistry in Health and Disease. Switzerland: Springer International Publishing; 2016; 13-26
27. Aung CS, Kruger WA, Poronnik P, Roberts-Thomson SJ, Monteith GR. Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation. Biochem Biophys Res Commun. 2007; 355:932-36
28. Ribiczey P, Tordai A, Andrikovics H, Filoteo AG, Penniston JT, Enouf J, Enyedi A, Papp B, Kovács T. Isoform-specific up-regulation of plasma membrane Ca2+ ATPase expression during colon and gastric cancer cell differentiation. Cell Calcium. 2007; 42:590-605
29. Cifuentes F, Vergara J, Hidalgo C. Sodium/calcium exchange in amphibian skeletal muscle fibers and isolated transverse tubules. Am J Physiol Cell Physiol. 2000; 279:C89-97
30. Wen J, Pang Y, Zhou T, Qi X, Zhao M, Xuan B, Meng X, Guo Y, Liu Q, Liang H, Li Y, Dong H, Wang Y. Essential role of Na+/Ca2+ exchanger 1 in smoking-induced growth and migration of esophageal squamous cell carcinoma. Oncotarget. 2016; 7:63816-28. https://doi.org/10.18632/oncotarget.11695
31. Dong H, Shim KN, Li JM, Estrema C, Ornelas TA, Nguyen F. Molecular mechanisms underlying Ca2+-mediated motility of human pancreatic duct cells. Am J Physiol Cell Physiol. 2010; 299:C1493-503
32. Iwamoto T, Watanabe Y, Kita S, Blaustein MP. Na+/Ca2+ exchange inhibitors: a new class of calcium regulators. Cardiovasc Hematol Disord Drug Targets. 2007; 7:188-98
33. Abdul M, Ramlal S, Hoosein N. Ryanodine receptor expression correlates with tumor grade in breast cancer. Pathol Oncol Res. 2008; 14:157-60
34. Mariot P, Prevarskaya N, Roudbaraki MM, Le Bourhis X, Van Coppenolle F, Vanoverberghe K, Skryma R. Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells. Prostate. 2000; 43:205-14
35. Drees BE, Andrews KM, Beckerlea MC. Molecular Dissection of Zyxin Function Reveals Its Involvement in Cell Motility. J Cell Biol. 1999; 147:1549-60
36. Yoshigi M, Hoffman LM, Jensen CC, Yost HJ, Beckerle MC. Mechanical force mobilizes zyxin from focal adhesions to actin filaments and regulates cytoskeletal reinforcement. J Cell Biol. 2005; 171:209-15
37. Hirota T, Morisaki T, Nishiyama Y, Marumoto T, Tada K, Hara T, Masuko N, Inagaki M, Hatakeyama K, Saya H. Zyxin, a Regulator of Actin Filament Assembly, Targets the Mitotic Apparatus by Interacting with H-Warts/Lats1 Tumor Suppressor. J Cell Biol. 2000; 149:1073-86
38. Crawford AW, Beckerle MC. Purification and characterization of zyxin, an 82,000-Dalton component of adherens junctions. J Biol Chem. 1991; 266:5847-53
39. Smith MA, Blankman E, Gardel ML, Luettjohann L, Waterman CM, Beckerle MC. A zyxin-mediated mechanism for actin stress fiber maintenance and repair. Dev Cell. 2010; 19:365-76
40. Oldenburg J, van der Krogt J, Twiss F, Bongaarts A, Habani Y, Slotman JA. VASP, zyxin and TES are tension-dependent members of Focal Adherens Junctions independent of the a-catenin-vinculin module. Sci Rep. 2015; 5:17225
41. Yonemura S. Actin filament association at adherens junctions. J Med Invest. 2017; 64:14-9
42. Ghosh S, Kollar B, Nahar T, Suresh Babu S, Wojtowicz A, Sticht C, Gretz N, Wagner AH, Korff T, Hecker M. Loss of the mechanotransducer zyxin promotes a synthetic phenotype of vascular smooth muscle cells. J Am Heart Assoc. 2015; 4:e001712
43. Indran IR, Tufo G, Pervaiz P, Brenner C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta. 2011; 1807:735-45
44. Chiche J, Rouleau M, Gounon P, Brahimi-Horn MC, Pouysségur J, Mazure NM. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J Cell Physiol. 2010; 222:648-57
45. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol. 2009; 19:57-66
46. Weinberg SE, Chandel NS. Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol. 2015; 11:9-15
47. Gerace L, Gilmore R, Johnson A, Lazarow P, Neupert W, O'Shea E. Intracellular compartments and protein sorting. In: Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P, editors. Molecular Biology of the Cell. New York: Garland Science; 2002; 1767-1819
48. Mrschtik M, Ryan KM. Lysosomal proteins in cell death and autophagy. FEBS J. 2015; 282:1858-70
49. Luzio JP, Pryor PR, Bright NA. Lysosomes: fusion and function. Nat Rev Mol Cell Biol. 2007; 8:622-32
50. Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014; 20:460-73
51. Falk H, Forde PF, Bay ML, Mangalanathan UM, Hojman P, Soden DM, Gehl J. Calcium electroporation induces tumor eradication, long-lasting immunity and cytokine responses in the CT26 colon cancer mouse model. Oncoimmunology. 2017; 6:e1301332
52. Falk H, Matthiessen LW, Wooler G, Gehl J. Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy. Acta Oncol. 2017; 17:1-9
53. Kulbacka J, Paczuska J, Rembialkowska N, Saczko J, Kielbowicz Z, Kinda W. Electrochemotherapy combined with standard and CO2 laser surgeries in canine oral melanoma Slov Vet Res. 2017; 54:181-6
54. Bouché M, Senni MI, Grossi AM, Zappelli F, Polimeni M, Arnold HH, Cossu G, Molinaro M. TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. Exp Cell Res. 1993; 208:209-17
55. Elkalaf M, Andel M, Trnka J. Low glucose but not galactose enhances oxidative mitochondrial metabolism in C2C12 myoblasts and myotubes. PLoS One. 2013; 8:e70772